We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
-4.53%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$428M
AUM Growth
+$11.3M
Cap. Flow
+$27.5M
Cap. Flow %
6.43%
Top 10 Hldgs %
8.45%
Holding
777
New
181
Increased
140
Reduced
102
Closed
354

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$3.76M
2
ETN icon
Eaton
ETN
+$3.69M
3
LYFT icon
Lyft
LYFT
+$3.26M
4
HLT icon
Hilton Worldwide
HLT
+$3.26M
5
XYL icon
Xylem
XYL
+$3.11M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$3.4M
2
VRSN icon
VeriSign
VRSN
+$2.68M
3
SNPS icon
Synopsys
SNPS
+$2.57M
4
GL icon
Globe Life
GL
+$2.4M
5
MDLZ icon
Mondelez International
MDLZ
+$2.29M

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Industrials 17.12%
3 Healthcare 13.81%
4 Consumer Discretionary 12.81%
5 Financials 12.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
351
Target
TGT
$65.6B
$331K 0.08%
+2,238
New +$352K
AES icon
352
AES
AES
$10.6B
$330K 0.08%
18,801
-73,199
-80% -$1.39M
KEX icon
353
Kirby Corp
KEX
$7.08B
$328K 0.08%
+2,742
New +$306K
WFRD icon
354
Weatherford International
WFRD
$6.07B
$327K 0.08%
+2,669
New +$319K
COKE icon
355
Coca-Cola Consolidated
COKE
$12.6B
$327K 0.08%
+3,010
New +$279K
AVY icon
356
Avery Dennison
AVY
$13.4B
$326K 0.08%
+1,489
New +$331K
INFA
357
DELISTED
Informatica
INFA
$321K 0.08%
10,405
+605
+6% +$19.1K
ACAD icon
358
Acadia Pharmaceuticals
ACAD
$4.55B
$320K 0.07%
19,680
+2,901
+17% +$46.8K
DAY
359
DELISTED
Dayforce
DAY
$317K 0.07%
+6,383
New +$365K
WH icon
360
Wyndham Hotels & Resorts
WH
$5.65B
$311K 0.07%
4,197
-15,903
-79% -$1.15M
EME icon
361
Emcor
EME
$35.4B
$306K 0.07%
+839
New +$310K
FNF icon
362
Fidelity National Financial
FNF
$14B
$305K 0.07%
6,175
-1,725
-22% -$86.8K
LDOS icon
363
Leidos
LDOS
$14.1B
$300K 0.07%
2,057
-2,643
-56% -$369K
UPWK icon
364
Upwork
UPWK
$1.14B
$288K 0.07%
26,810
-11,190
-29% -$127K
WFC icon
365
Wells Fargo
WFC
$258B
$285K 0.07%
+4,799
New +$283K
KLG
366
DELISTED
WK Kellogg Co
KLG
$282K 0.07%
17,162
-4,238
-20% -$86K
AGCO icon
367
AGCO
AGCO
$7.76B
$277K 0.06%
2,828
-2,672
-49% -$298K
EPAM icon
368
EPAM Systems
EPAM
$5.42B
$276K 0.06%
1,465
-4,495
-75% -$958K
INGR icon
369
Ingredion
INGR
$6.33B
$274K 0.06%
2,388
-812
-25% -$93.8K
KO icon
370
Coca-Cola
KO
$381B
$274K 0.06%
+4,297
New +$266K
SFM icon
371
Sprouts Farmers Market
SFM
$8.1B
$273K 0.06%
3,263
-3,737
-53% -$272K
COHR icon
372
Coherent
COHR
$48.7B
$272K 0.06%
3,758
-8,242
-69% -$496K
MRVI icon
373
Maravai LifeSciences
MRVI
$996M
$272K 0.06%
37,982
-13,093
-26% -$113K
CROX icon
374
Crocs
CROX
$6.14B
$269K 0.06%
+1,844
New +$259K
TEX icon
375
Terex
TEX
$7.11B
$266K 0.06%
+4,849
New +$288K

Similar funds

AXQ Capital's Q2 2024 Portfolio in Review

As of Q2 2024, AXQ Capital held 777 positions worth $428M, up 2.7% from $417M the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

AXQ Capital deployed $27.5M of net new capital in Q2 2024, opening 181 new positions and adding to 140 existing holdings. Its largest new stake was Walgreens Boots Alliance: 221,738 shares worth $2.68M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $1.57M trimmed.

  • AXQ Capital's largest Q2 2024 buy was Walgreens Boots Alliance: 221,738 shares worth $2.68M.
  • AXQ Capital added most to Xylem in Q2 2024, an estimated $3.11M increase.
  • AXQ Capital's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.57M.
  • AXQ Capital fully exited S&P Global in Q2 2024, selling an estimated $3.4M.
  • AXQ Capital's ten largest holdings make up 8.5% of its $428M portfolio in Q2 2024.
  • AXQ Capital opened 181 new positions and closed 354 in Q2 2024.
  • AXQ Capital's portfolio value rose 2.7% quarter-over-quarter to $428M.

Based on AXQ Capital's 13F filing for Q2 2024, filed 13 Aug 2024.